An inhibitor of Ca2+/calmodulin-dependent protein kinase II, KN-62, inhibits cholinergic-stimulated parietal cell secretion
Yasuhiro Tsunoda(Shinshu University), James R. Goldenring(Vanderbilt University), Linda M. Fox(Loyola University Chicago), Hisashi Hidaka(Kitasato University), Irvin M. Modlin(Yale University), M. Funasaka(Yale University)
American Journal of Physiology-Gastrointestinal and Liver Physiology
January 1, 1992
Cited by 28
Related Papers
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k
Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells.
|Journal of Biological Chemistry|1990|1.5k
KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II.
|Journal of Biological Chemistry|1990|625
N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation.
|Proceedings of the National Academy of Sciences|1981|586
Selective inhibition of catalytic activity of smooth muscle myosin light chain kinase.
|Journal of Biological Chemistry|1987|513